Alexey Novikov

Alexey Novikov

Auto-generated profile, based on publicly available information

Alexey Novikov

Yudin City Clinical Hospital

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2024 in Urology Herald
Verified
Journal Article
Open access
PDF file
SKS. V. Kotov
S. V. Kotov
RPR. A. Perov
R. A. Perov
IZI. A. Zhestkov
I. A. Zhestkov
ANA. A. Novikov
A. A. Novikov
ANA. A. Nemenov
A. A. Nemenov
Introduction. To date, there has been insufficient research into the prostate volume as a factor that may influence the effectiveness and safety of surgical treatments. With the advent of relatively new laser techniques, it is important to take a closer look at this parameter, especially considering the success of these techniques in the treatment of benign prostatic hyperplasia (BPH) of various volumes.Objective. To assess the functional outcomes and postoperative complications of holmium laser enucleation of the prostate (HoLEP) depending on its volume.Materials & Methods. We performed a prospective study of HoLEP on 252 patients. Patients were divided into two groups according to their prostate volume: Group I included 206 patients (81%) with a prostate volume of < 100 mL, and Group II included 46 patients (19%) with a prostate volume ≥ 100 mL.Results. The prostate volume was the most significant prognostic factor regarding duration of surgery. This indicator significantly differed between the two groups. Group I had an average surgery time of 67.1 ± 26.7 minutes, while Group II had a time of 98.1 ± 24.2 minutes (p < 0.05). There were no significant differences in the number of complications between the groups — 36 cases (17.5%) in Group I and 12 cases (26%) in Group II, as well as functional results of urination between the groups. In the early postoperative period, the Q max in Group I was 17.4 ± 9.1 ml/s, in Group II — 18.2 ± 10.9 ml/s (p > 0.05), PVR — 52 ± 39.4 and 56 ± 31.8 ml (p > 0.05), respectively. After 3 months of observation, there were also no differences in the studied parameters: IPSS — 5.7 ± 4.1 vs 6.2 ± 4.9 points; QoL — 1.0 ± 0.9 vs 1.1 ± 0.9 points; Q max — 18.9 ± 6.7 vs 20.3 ± 11.5 ml/s; PVR — 53.5 ± 33.1 vs 54.9 ± 30.6 ml (p > 0.05).Conclusion. HoLEP is an effective and safe method of treating patients with different volumes of BPH. However, the duration of the procedure is an important factor that influences the surgery outcome, as it correlates with the prostate volume.

1 January 2023 in Астраханский вестник экологического образования
Verified
Journal Article
Closed access
SPState University of Land Use Planning
State University of Land Use Planning
ANAlexey Novikov
Alexey Novikov
IKIrina Khabarova
Irina Khabarova
DKDenis Khabarov
Denis Khabarov
SMState University of Management
State University of Management

25 December 2022 in Experimental and Сlinical Urology
Verified
Journal Article
Open access
SKS.V. Kotov
S.V. Kotov
UUurology and andrology department of the N.I. Pirogov Russian National Research Medical University
urology and andrology department of the N.I. Pirogov Russian National Research Medical University
RPR.A. Perov
R.A. Perov
ANA.A. Novikov
A.A. Novikov
RMRussia Moscow
Russia Moscow
Introduction. The influence of the age phenomenon on the outcome of the surgical treatment of benign prostate hyperplasia (BPH) research is insufficient. Considering the wide use of the more advanced laser enucleation method in the surgical treatment of BPH, there is a need to evaluate the efficiency and safety of this technique among aged patients compared to younger age groups. In this review the task was to evaluate the impact of the age phenomenon on the result of treatment, using the available scientific literature. Materials and methods. Articles were searched in three databases (Pubmed, Scopus and Web of Science) using the following request: «laser enucleation», «prostate», «elderly patients», «older patients» and «age». The unsystematic review of 7 works in English containing original data demonstrated the results of different types of enucleation among the patients with a clear stratification of groups by age for the period 2013-2022 was made. Results. Тhe absolute majority of studies do not show significant differences between the age groups regarding the preoperative IPSS, Qmax, post-void residual (PVR), however, a high frequency of chronic diseases in the older age group is noticed. In most studies, no significant differences in a number of complications according to Clavien-Dindo were found. Only in one study P. Gild et al., where large samples were researched, the frequency of blood transfusions and a number of complications ≥3b, were much higher in a group of patients over 80 y.o. and older comparing to younger-aged groups: 0 (0%), 8 (1,3%), 22 (2,7%), 14 (8,2%) for the group under 60 years old, 60-69 years old, 70-79 years old, 80 years and older, respectively (p<0,001); 2 (1,5%), 12 (1,9%), 34 (3,9%), 13 (7,1%), for these groups, respectively (p=0,02). Regarding the postoperative Qmax, despite of significant improvement of this indicator in all age groups, worse results are noticed in older patients group comparing to the results of patients in younger groups. However, the tendency to balance the marked differences with a long observation period is also noticed. Conclusions. Laser enucleation of the prostate is the effective and safe method for prostatic hyperplasia treatment for the patients of any age. However, available data about bad results after the surgical treatment among elderly patients and a higher frequency of complications show the need of the further research of this topic and evaluation of the surgical treatment at an earlier age.